Global Tissue Sealants Clinical Pipeline Research Report 2023: Stages of Development, Segments, Region and Countries, Regulatory Path and Competitive Landscape

News provided by

Jan 16, 2024, 10:30 ET

DUBLIN, Jan. 16, 2024 /PRNewswire/ -- The "Tissue Sealants Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" report has been added to ResearchAndMarkets.com's offering.

The Medical Devices sector report provides comprehensive information about the Tissue Sealants pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Tissue sealants serve primarily as a physical barrier to prevent leakage of fluid and/or gas from a surgical incision.

Scope

Extensive coverage of the Tissue Sealants under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Tissue Sealants and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry

Reasons to Buy

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Tissue Sealants under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Tissue Sealants Overview

3 Products under Development
3.1 Tissue Sealants - Pipeline Products by Stage of Development
3.2 Tissue Sealants - Pipeline Products by Segment
3.3 Tissue Sealants - Pipeline Products by Territory
3.4 Tissue Sealants - Pipeline Products by Regulatory Path
3.5 Tissue Sealants - Pipeline Products by Estimated Approval Date
3.6 Tissue Sealants - Ongoing Clinical Trials

4 Tissue Sealants - Pipeline Products under Development by Companies
4.1 Tissue Sealants Companies - Pipeline Products by Stage of Development
4.2 Tissue Sealants - Pipeline Products by Stage of Development

5 Tissue Sealants Companies and Product Overview

6 Tissue Sealants- Recent Developments

7 Appendix

A selection of companies mentioned in this report includes

Advanced Medical Solutions Group plc
Aleo BME Inc
Angiotech Pharmaceuticals Inc
Arch Therapeutics Inc
Arizona State University
Baxter International Inc
Biomedica Management Corp
Boston University
Calmare Therapeutics Inc
Clemson University
Cohera Medical Inc
Covalent Medical, Inc. (Inactive)
CR Bard Inc
Department of Biomedical Engineering Columbia University
DSM Biomedical BV
Eidgenossische Materialprufungs- und Forschungsanstalt
Elastagen Pty Ltd
Ethicon Endo-Surgery Inc
Gamma Diagnostics Inc
GATT Technologies BV
Hemostasis LLC
HyperBranch Medical Technology Inc
Innotherapy Inc
Institute of Molecular Biology of Parana
InVivo Therapeutics Corp
Johns Hopkins University
Kollodis BioSciences Inc
Kuros Biosciences AG
Laser Tissue Welding, Inc.
Medisse BV (Inactive)
Meril Life Sciences Pvt Ltd
Nurami Medical Ltd
Pharming Group NV
Polyganics BV
Protein Polymer Technologies Inc (Inactive)
Purdue University
Samyang Biopharmaceuticals Corp
Sea Run Holdings Inc
Sealantis Ltd.
Sealonix Inc
Selio Medical
Shanghai Haohai Biological Technology Co Ltd
Surgical Sealants, Inc.
Teijin Pharma Ltd
Terasaki Institute for Biomedical Innovation
Tetratherix Pty Ltd
Texas A&M Engineering Experiment Station
Texas A&M University
The Medicines Co
Tissium SA
University of Akron

For more information about this report visit https://www.researchandmarkets.com/r/cz6of8

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets